10 Jun 2014 Idenix Pharma’s $1 Billion Winner: Seth Klarman ( Portfolio )

Baupost’s position in Idenix was valued at about $302 million as of the end of the first quarter, according to a recent 13F filing. Based on Monday’s closing price, the stake is worth about $1.27 billion.